title: Are lymphokine activated killer cells a possible form of leukaemia immunotherapy?
authors.affiliation: Alfred Hospital, Prahran, Australia.
authors.forename: J A
authors.initials: JA
authors.lastname: Tratkiewicz
authors.forename: J
authors.initials: J
authors.lastname: Szer
authors.forename: R L
authors.initials: RL
authors.lastname: Boyd
mesh_terms: D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D066298:In Vitro Techniques; D007694:Killer Cells, Natural / Q000276:immunology*; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000494:pharmacology
chemical_list: D008222:Lymphokines